Trials / Active Not Recruiting
Active Not RecruitingNCT06912659
The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib
Non-interventional Prospective Study in Patients With Pulmonary Fibrosis Treated With Nintedanib Participating in a Patient Support Program in Spain, to Describe Patient Satisfaction With the Program and to Monitor Quality of Life - BALANCE Study
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 157 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to describe patients' satisfaction with Patient Support Program (Balance Program), Quality of Life and depression symptoms, dosing pattern, disease symptoms, adverse events and nintedanib discontinuation (both permanent and non-permanent) from study inclusion to 12 months of follow-up.
Conditions
Timeline
- Start date
- 2025-06-23
- Primary completion
- 2026-12-23
- Completion
- 2026-12-23
- First posted
- 2025-04-06
- Last updated
- 2026-01-08
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06912659. Inclusion in this directory is not an endorsement.